Child and Adolescent Psychiatric Disorders

Massachusetts General Hospital Comprehensive Clinical Psychiatry

Volumn , Issue , 2008, Pages 937-959

  Bostic, Jeff Q ^a,b   Prince, Jefferson B ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NORTH SHORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85166145229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04743-2.50071-8     Document Type: Chapter

References (52)

1. Diagnostic and statistical manual of mental disorders, fourth edition, text revision Washington, DC: American Psychiatric Association
2. SD Connolly and GA Bernstein (2007) Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 46 267-283.
3. MA Garvey, SJ Perlmutter, AJ Allen, et al. (1999) A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45 1564-1571.
4. SE Swedo, HL Leonard, M Garvey, et al. (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases (comment). Am J Psychiatry 155 264-271..[Erratum appears in Am J Psychiatry 155(4):578, 1998.]
5. J March and K Mulle (1998) OCD in children and adolescents: a cognitive-behavioral treatment manual New York: Guilford
6. CL Donnelly (2003) Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin North Am 12 251-269.
7. MB Himle, DW Woods, JC Piacentini and JT Walkup (2006) Brief review of habit reversal training for Tourette syndrome. J Child Neurol 21 719-725.
8. GR Gaffney, PJ Perry, BC Lund, et al. (2002) Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 41 330-336.
9. Tourette's Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial (comment). Neurology 58 527-536.
10. FR Sallee, R Kurlan, CG Goetz, et al. (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39 292-299.
11. L Scahill, JF Leckman, RT Schultz, et al. (2003) A placebo-controlled trial of risperidone in Tourette's syndrome. Neurology 60 1130-1135.
12. L Davies, JS Stern, N Agrawal and MM Robertson (2006) A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol 21 447-453.
13. PS Jensen, JA Garcia, S Glied, et al. (2005) Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry 162 1628-1636.
14. MTA Cooperative Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113 762-769.
15. T Wilens, S Faraone, J Biederman, et al. (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 179-185.
16. DF Connor, KE Fletcher and JM Swanson (1999) A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38 1551-1559.
17. RW Greene, JS Ablon, JC Goring, et al. (2004) Effectiveness of collaborative problem solving in affectively dysregulated children with oppositional-defiant disorder: initial findings. Consult Clin Psychol 72 1157-1164.
18. H Steiner and L Remsing (2007) Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 46 126-141.
19. B Geller, B Zimerman, M Williams, et al. (2001) Adult psychosocial outcome of prepubertal major depressive disorder. J Am Acad Child Adolesc Psychiatry 40 673-677.
20. DR Demaso, NE Marcus, C Kinnamon and J Gonzalez-Heydrich (2006) Depression experience journal: a computer-based intervention for families facing childhood depression. J Am Acad Child Adolesc Psychiatry 45 158-165.
21. AB Klomek and L Mufson (2006) Interpersonal psychotherapy for depressed adolescents. Child Adolesc Psychiatr Clin North Am 15 959-975.
22. GJ Emslie, ND Ryan and KD Wagner (2005) Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy. J Clin Psychiatry 66(suppl 7), 14-20.
23. GJ Emslie, AJ Rush, WA Weinberg, et al. (1997) A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54 1031-1037.
24. GJ Emslie, JH Heiligenstein, KD Wagner, et al. (2002) Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41 1205-1215.
25. J March, S Silva, S Petrycki, et al. (2004) Treatment for Adolescents with Depression Study (TADS) team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 292(7), 807-820.
26. KD Wagner, AS Robb, RL Findling, et al. (2004) A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161(6), 1079-1083.
27. BE Hamilton, AM Minino, JA Martin, et al. (2005) Annual summary of vital statistics: 2005. Pediatrics 119 345-360.
28. N Rappaport, J Prince and JQ Bostic (2005) Lost in the black box: juvenile depression, suicidality, and the FDA's black box. J Pediatrics 147 719-720.
29. CJ Kratchovil, B Vitiello, DA Brent, et al. (2006) Selecting an antidepressant for the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45 371-373.
30. N Rappaport, JQ Bostic, J Prince and M Jellinek (2006) Treating pediatric depression in primary care: coping with the patient's blue mood and the FDA's black box. J Pediatrics 148 567-568.
31. J McClellan, J Werry, W Ayres, et al. (2007) Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46 107-125.
32. TJ Spencer, J Biederman, J Wozniak, et al. (2001) Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biol Psychiatry 49 1062-1070.
33. RA Kowatch, T Suppes, TJ Carmody, et al. (2000) Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39 713-720.
34. M Mandoki (1997) Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents. Biol Psychiatry 41 93S-94S.
35. American Diabetic Association (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27 596-601.
36. JA Frazier, J Biederman, M Tohen, et al. (2001) A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11 239-250.
37. MP Delbello, ML Schwiers, HL Rosenberg, et al. (2002) A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41 1216-1223.
38. H Honda, Y Shimizu, M Imai and Y Nitto (2005) Cumulative incidence of childhood autism: a total population study of better accuracy and precision. Dev Med Child Neurol 47(1), 10-18.
39. B King and JQ Bostic (2006) An update on pharmacological treatment for autism spectrum disorders. Child Adolesc Psychiatry Clin North Am 15 161-176.
40. www.thegraycenter.org
41. www.kennedykrieger.org
42. JT McCracken, J McGough, B Shah, et al. (2002) Risperidone in children with autism and serious behavioral problems (comment). N Engl J Med 347 314-321.
43. K Horvath, G Stefanatos, KN Sokolski, et al. (1998) Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 9 9-15.
44. P Sturmey (2005) Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil 26 87-97.
45. A Khurana, A Aminzadeh, JQ Bostic and C Pataki (2007) Childhood-onset schizophrenia: diagnostic and treatment challenges. Psychiatric Times 24 33-36.
46. R Ross, S Heinlein and H Tregellas (2006) High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr Res 88(1-3), 90-95.
47. M Remschmidt, C Martin and C Fleischhaker (2007) Forty-two years later: the outcome of childhood-onset schizophrenia. J Neural Transm 114(4), 505-512.
48. RG Ross, D Novins, GK Farley and LE Adler (2003) A 1-year open-label trial of olanzapine in school-age children with schizophrenia. J Child Adolesc Psychopharmacol 13 301-309.
49. P Shaw, A Sporn, N Gogtay, et al. (2006) Childhood-onset schizophrenia, a double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry 63 721-730.
50. S Kumra, JA Frazier, LK Jacobsen, et al. (1996) Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 53 1090-1097.
51. Sikich L, McClellan J, Lieberman JA, et al: Initial findings from the early-onset schizophrenia spectrum disorder research group. Symposium presented at the 53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 24-29, 2006, San Diego.
52. RL Findling, JA Frazier, G Gerbino-Rosen, et al. (2007) Is there a role for clozapine in the treatment of children and adolescents? J Am Acad Child Adolesc Psychiatr 46 423-428.